Tapewire

OTC · USD

RBOT

Vicarious Surgical Inc.

Export transactions ↓
Tapewire entity
8714
SEC CIK
0001812173
Parsed reports
348

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202502
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 02, 2022 Filed Mar 4, 2022 21:50 UTC
Liang PhilipDirector
OtherClass A Common Stock 66,497 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-010770 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Chelvey International Limited

Disclosed balance after: 2,389,644

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration.

F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 00:25 UTC
Liang PhilipDirector
OtherClass A Common Stock 265,990 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-009861 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Chelvey International Limited

Disclosed balance after: 2,456,141

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration.

F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.

Read SEC document
February 16, 2022 Filed Feb 18, 2022 21:55 UTC
Liang PhilipDirector
OtherClass A Common Stock 265,990 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-008500 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Chelvey International Limited

Disclosed balance after: 2,722,131

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration.

F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.

Read SEC document
February 07, 2022 Filed Feb 9, 2022 18:05 UTC
E15 Fund II, LPFormer 10% Owner
Liang PhilipDirector · Former 10% Owner
Patnaik ShrikantFormer 10% Owner
OtherClass A Common Stock 6,649,744 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-006211 · ownership.xml · nonDerivative · entry 1

Chelvey International Ltd · CIK 0001884829 · Former 10% Owner

E15 Fund II, LP · CIK 0001885992 · Former 10% Owner

Liang Philip · CIK 0001883781 · Director · Former 10% Owner

Patnaik Shrikant · CIK 0001885980 · Former 10% Owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,988,121

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration.

F2 · balance_after: E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. Philip Liang is the managing partner of E15 Fund II, LP and Shrikant Patnaik is a principal of E15 Fund II, LP and may be deemed to share voting and dispositive power over the shares held by Chelvey International Limited. Such persons and entities disclaim beneficial ownership of shares held by Chelvey International Limited, except to the extent of any pecuniary interest therein.

Read SEC document
February 07, 2022 Filed Feb 9, 2022 23:07 UTC
Liang PhilipDirector
OtherClass A Common Stock 6,649,744 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-006213 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Chelvey International Limited

Disclosed balance after: 2,988,121

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration.

F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.

Read SEC document
February 02, 2022 Filed Feb 3, 2022 19:04 UTC
Kelly William JohnCFO and Treasurer
SaleClass A Common Stock 2,068 $6.32 $13,069.76
Disclosure

SEC source: 0001213900-22-005329 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,809

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

Read SEC document
January 31, 2022 Filed Feb 2, 2022 19:10 UTC
Liang PhilipDirector · 10% owner
OtherClass A Common Stock 398,985 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-005113 · ownership.xml · nonDerivative · entry 1

Chelvey International Ltd · CIK 0001884829 · 10% owner

E15 Fund II, LP · CIK 0001885992 · 10% owner

Liang Philip · CIK 0001883781 · Director · 10% owner

Patnaik Shrikant · CIK 0001885980 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,637,865

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration.

F2 · balance_after: E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. Philip Liang is the managing partner of E15 Fund II, LP and Shrikant Patnaik is a principal of E15 Fund II, LP and may be deemed to share voting and dispositive power over the shares held by Chelvey International Limited. Such persons and entities disclaim beneficial ownership of shares held by Chelvey International Limited, except to the extent of any pecuniary interest therein.

Read SEC document
January 31, 2022 Filed Feb 3, 2022 00:08 UTC
Liang PhilipDirector · 10% owner
OtherClass A Common Stock 398,985 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-005111 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Chelvey International Limited

Disclosed balance after: 9,637,865

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration.

F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.

Read SEC document
January 25, 2022 Filed Jan 26, 2022 16:09 UTC
Morris JuneCLO, Gen. Counsel, Secretary
SaleClass A Common Stock 2,210 $5.37 $11,867.70
Disclosure

SEC source: 0001213900-22-003742 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, Gen. Counsel, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,270

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 16:38 UTC
Sachs Adam DavidDirector · President and CEO · 10% owner
SaleClass A Common Stock 7,743 $7.30 $56,523.90
Disclosure

SEC source: 0001213900-22-002702 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,707

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 21:40 UTC
Khalifa SammyDirector · Chief Technology Officer · 10% owner
SaleClass A Common Stock 6,194 $7.31 $45,278.14
Disclosure

SEC source: 0001213900-22-002704 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,157

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $7.19 to $7.47 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

Read SEC document
December 31, 2021 Filed May 4, 2022 18:42 UTC
Ho David DDirector
GrantClass A Common Stock 1,104 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-024037 · ownership.xml · nonDerivative · entry 1

Ho David D · CIK 0001850976 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,813

F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of $12,177 of cash retainer fees earned during the third and fourth quarters of 2021. The RSUs were fully vested on the grant date.

Read SEC document
December 31, 2021 Filed May 4, 2022 18:38 UTC
Kaul SamirDirector · 10% owner
GrantClass A Common Stock 1,320 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-024035 · ownership.xml · nonDerivative · entry 1

Kaul Samir · CIK 0001501915 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,029

F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of $14,555 of cash retainer fees earned during the third and fourth quarters of 2021. The RSUs were fully vested on the grant date.

Read SEC document
December 31, 2021 Filed May 4, 2022 22:32 UTC
Liang PhilipDirector
GrantClass A Common Stock 1,200 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-024032 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,309,999

F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of $13,237 of cash retainer fees earned during the third and fourth quarters of 2021. The RSUs were fully vested on the grant date.

Read SEC document
December 20, 2021 Filed Dec 22, 2021 15:11 UTC
Kelly William JohnCFO and Treasurer
Tax withholdingClass A Common Stock 1,185 $10.09 $11,956.65
Disclosure

SEC source: 0001213900-21-066962 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,877

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

Read SEC document
December 20, 2021 Filed Dec 22, 2021 15:09 UTC
Sachs Adam DavidDirector · President and CEO · 10% owner
Tax withholdingClass A Common Stock 4,437 $10.09 $44,769.33
Disclosure

SEC source: 0001213900-21-066960 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,450

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

Read SEC document
December 20, 2021 Filed Dec 22, 2021 15:08 UTC
Morris JuneCLO, General Counsel & Sec.
Tax withholdingClass A Common Stock 1,008 $10.09 $10,170.72
Disclosure

SEC source: 0001213900-21-066958 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, General Counsel & Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,480

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

Read SEC document
December 20, 2021 Filed Dec 22, 2021 20:13 UTC
Khalifa SammyDirector · Chief Technology Officer · 10% owner
Tax withholdingClass A Common Stock 3,549 $10.09 $35,809.41
Disclosure

SEC source: 0001213900-21-066966 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,351

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:40 UTC
Kelly William JohnCFO and Treasurer
GrantStock Option (right to buy) · Derivative 104,125 $0.00 Strike: $12.45 $0.00
Disclosure

SEC source: 0001213900-21-062145 · ownership.xml · derivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,125

Underlying: Class A Common Stock · 104,125 shares

Expires 2021-11-23

F2 · derivative.exercise_date: The shares underlying this option vest in equal monthly installments over 48 months beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Kelly's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:40 UTC
Kelly William JohnCFO and Treasurer
GrantClass A Common Stock 52,062 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062145 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,062

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 16 equal quarterly installments beginning on September 20, 2021, provided that the initial quarterly vesting installment will not occur until December 20, 2021, subject to Mr. Kelly's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:37 UTC
Sachs Adam DavidDirector · President and CEO · 10% owner
GrantStock Option (right to buy) · Derivative 389,774 $0.00 Strike: $12.45 $0.00
Disclosure

SEC source: 0001213900-21-062140 · ownership.xml · derivative · entry 2

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 389,774

Underlying: Class A Common Stock · 389,774 shares

Expires 2021-11-23

F2 · derivative.exercise_date: The shares underlying this option vest in equal monthly installments over 48 months beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Sachs' continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:37 UTC
Sachs Adam DavidDirector · President and CEO · 10% owner
GrantClass A Common Stock 194,887 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062140 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,887

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 16 equal quarterly installments beginning on September 20, 2021, provided that the initial quarterly vesting installment will not occur until December 20, 2021, subject to Mr. Sachs' continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:37 UTC
Morris JuneCLO, Gen. Counsel & Secretary
GrantStock Option (right to buy) · Derivative 102,977 $0.00 Strike: $12.45 $0.00
Disclosure

SEC source: 0001213900-21-062138 · ownership.xml · derivative · entry 2

Morris June · CIK 0001884658 · CLO, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,977

Underlying: Class A Common Stock · 102,977 shares

Expires 2021-11-23

F2 · derivative.exercise_date: The shares underlying this option vest in equal monthly installments over 48 months beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Ms. Morris' continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:37 UTC
Morris JuneCLO, Gen. Counsel & Secretary
GrantClass A Common Stock 51,488 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062138 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,488

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 16 equal quarterly installments beginning on September 20, 2021, provided that the initial quarterly vesting installment will not occur until December 20, 2021, subject to Ms. Morris' continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:36 UTC
Ho David DDirector
GrantClass A Common Stock 9,624 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062137 · ownership.xml · nonDerivative · entry 2

Ho David D · CIK 0001850976 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,624

F2 · price: Consists of RSUs. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Dr. Ho's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:36 UTC
Ho David DDirector
GrantClass A Common Stock 26,085 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062137 · ownership.xml · nonDerivative · entry 1

Ho David D · CIK 0001850976 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,085

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Dr. Ho's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:40 UTC GrantClass A Common Stock 9,624 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062144 · ownership.xml · nonDerivative · entry 2

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,624

F2 · price: Consists of RSUs. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Tang's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:40 UTC GrantClass A Common Stock 26,085 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062144 · ownership.xml · nonDerivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,085

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Tang's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:35 UTC
Fulop RicDirector
GrantClass A Common Stock 9,624 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062136 · ownership.xml · nonDerivative · entry 1

Fulop Ric · CIK 0001472305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,624

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Fulop's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:38 UTC
Kaul SamirDirector · 10% owner
GrantClass A Common Stock 9,624 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062141 · ownership.xml · nonDerivative · entry 2

Kaul Samir · CIK 0001501915 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,624

F2 · price: Consists of RSUs. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Kaul's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 13:38 UTC
Kaul SamirDirector · 10% owner
GrantClass A Common Stock 26,085 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062141 · ownership.xml · nonDerivative · entry 1

Kaul Samir · CIK 0001501915 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,085

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Kaul's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 18:39 UTC GrantClass A Common Stock 9,624 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062143 · ownership.xml · nonDerivative · entry 1

Styka David Michael · CIK 0001884339 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,624

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Styka's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 18:39 UTC
Khalifa SammyDirector · CTO · 10% owner
GrantStock Option (right to buy) · Derivative 311,819 $0.00 Strike: $12.45 $0.00
Disclosure

SEC source: 0001213900-21-062142 · ownership.xml · derivative · entry 2

Khalifa Sammy · CIK 0001883777 · Director · CTO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 311,819

Underlying: Class A Common Stock · 311,819 shares

Expires 2021-11-23

F2 · derivative.exercise_date: The shares underlying this option vest in equal monthly installments over 48 months beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Khalifa's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 18:39 UTC
Khalifa SammyDirector · CTO · 10% owner
GrantClass A Common Stock 155,900 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062142 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · CTO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,900

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 16 equal quarterly installments beginning on September 20, 2021, provided that the initial quarterly vesting installment will not occur until December 20, 2021, subject to Mr. Khalifa's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 18:37 UTC
Liang PhilipDirector · 10% owner
GrantClass A Common Stock 9,624 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062139 · ownership.xml · nonDerivative · entry 2

Liang Philip · CIK 0001883781 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,624

F2 · price: Consists of RSUs. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Liang's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 18:37 UTC
Liang PhilipDirector · 10% owner
GrantClass A Common Stock 26,085 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062139 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,085

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Liang's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 18:35 UTC
Berman DrorDirector · 10% owner
GrantClass A Common Stock 9,624 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062135 · ownership.xml · nonDerivative · entry 2

Berman Dror · CIK 0001883780 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,624

F2 · price: Consists of RSUs. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Berman's continued service through the applicable vesting date.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 18:35 UTC
Berman DrorDirector · 10% owner
GrantClass A Common Stock 26,085 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-062135 · ownership.xml · nonDerivative · entry 1

Berman Dror · CIK 0001883780 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,085

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Berman's continued service through the applicable vesting date.

Read SEC document
September 17, 2021 Filed Sep 22, 2021 00:58 UTC
KHOSLA VINOD10% owner
PurchaseCLASS A COMMON STOCK 333,334 $10.00 $3,333,340.00
Disclosure

SEC source: 0000899243-21-036918 · doc4.xml · nonDerivative · entry 1

Khosla Ventures V, L.P. · CIK 0001611146 · 10% owner

Khosla Ventures Associates V, LLC · CIK 0001611145 · 10% owner

VK Services, LLC · CIK 0001501927 · 10% owner

KHOSLA VINOD · CIK 0001032453 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 13,059,335

F1 · ownership.nature: Consists of securities held of record by Khosla Ventures V, L.P. ("KV V"), of which Khosla Ventures Associates V, LLC ("KVA V") is the general partner. Vinod Khosla is the managing member of VK Services, which is the sole manager of KVA V. Each of KVA V, VK Services and Vinod Khosla may be deemed to possess voting and investment control over such securities held by KV V, and each of KVA V, VK Services, and Vinod Khosla may be deemed to have indirect beneficial ownership of such securities held by KV V. Each Reporting Person disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interests therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

Read SEC document
September 17, 2021 Filed Sep 21, 2021 21:00 UTC
D8 Sponsor LLCDirector · 10% owner · Director by Deputization
CHU DAVIDDirector
Exercise / conversionClass B ordinary shares, par value $0.0001 per share · Derivative 8,535,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-049215 · ownership.xml · derivative · entry 2

D8 Sponsor LLC · CIK 0001813880 · Director · 10% owner · Director by Deputization

CHU DAVID · CIK 0001199554 · Director

Tang Donald F · CIK 0001817370 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A ordinary shares · 8,535,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock.

F1 · kind: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock.

F1 · derivative.exercise_date: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock.

F1 · derivative.expiration_date: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock.

Read SEC document
September 17, 2021 Filed Sep 21, 2021 21:00 UTC
D8 Sponsor LLCDirector · 10% owner · Director by Deputization
CHU DAVIDDirector
Exercise / conversionClass A common stock, par value $0.0001 per share 8,535,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-049215 · ownership.xml · nonDerivative · entry 1

D8 Sponsor LLC · CIK 0001813880 · Director · 10% owner · Director by Deputization

CHU DAVID · CIK 0001199554 · Director

Tang Donald F · CIK 0001817370 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,535,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock.

F1 · price: In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as D8 Holdings Corp. or "D8") and Vicarious Surgical Operating Co. (f/k/a Vicarious Surgical Inc.), among other things, (i) each of the then issued and outstanding Class B ordinary shares of D8 converted into Class A ordinary shares of D8 on a one-for-one basis as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-239503), (ii) D8 migrated to and domesticated as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended, and the Cayman Islands Companies Act (As Revised) (the "Domestication") and (iii) each of the issued and outstanding Class A ordinary shares of D8 converted into shares of the Issuer's (after the Domestication) Class A common stock.

F2 · balance_after: D8 Sponsor LLC is the record holder of the securities reported herein. David Chu and Donald Tang are the managers of D8 Sponsor LLC and share voting and investment discretion with respect to the shares of Class A common stock held of record by D8 Sponsor LLC. Each of the Messrs. Chu and Tang disclaims any beneficial ownership of the securities held by D8 Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly.

Read SEC document
September 17, 2021 Filed Sep 21, 2021 19:07 UTC
Fulop RicDirector
GrantStock Option (right to buy) · Derivative 409,702 Not disclosed Strike: $1.90 Not disclosed
Disclosure

SEC source: 0001213900-21-049176 · ownership.xml · derivative · entry 1

Fulop Ric · CIK 0001472305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,702

Underlying: Class A Common Stock · 409,702 shares

Expires 2031-02-24

F2 · price: In connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 15, 2021, by and among D8 Holdings Corp. ("D8"), Snowball Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of D8 ("Merger Sub"), and Vicarious Surgical Inc., a Delaware corporation ("Vicarious"), pursuant to which Merger Sub merged with and into Vicarious, with Vicarious surviving as a wholly-owned subsidiary of D8 (which changed its name to "Vicarious Surgical Inc.", the "Issuer"), these stock options were received in exchange for a stock option to acquire 124,216 shares of Vicarious common stock for $6.26 per share.

F1 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments beginning on January 25, 2021, subject to Mr. Fulop's continued service through the applicable vesting date.

Read SEC document
September 17, 2021 Filed Sep 21, 2021 23:10 UTC
Khalifa SammyDirector · Chief Technology Officer · 10% owner
GrantClass B Common Stock 4,551,668 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-049180 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,551,668

F1 · price: In connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 15, 2021, by and among D8 Holdings Corp. ("D8"), Snowball Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of D8 ("Merger Sub"), and Vicarious Surgical Inc., a Delaware corporation ("Vicarious"), pursuant to which Merger Sub merged with and into Vicarious, with Vicarious surviving as a wholly-owned subsidiary of D8 (which changed its name to "Vicarious Surgical Inc.", the "Issuer"), these shares were received in exchange for 1,380,000 Class A Common Stock of Vicarious.

Read SEC document
September 17, 2021 Filed Sep 23, 2021 00:39 UTC GrantStock Option (right to buy) · Derivative 1,273,197 Not disclosed Strike: $0.41 Not disclosed
Disclosure

SEC source: 0001213900-21-049424 · ownership.xml · derivative · entry 1

Styka David Michael · CIK 0001884339 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,273,197

Underlying: Class A Common Stock · 1,273,197 shares

Expires 2030-11-11

F2 · price: In connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 15, 2021, by and among D8 Holdings Corp. ("D8"), Snowball Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of D8 ("Merger Sub"), and Vicarious Surgical Inc., a Delaware corporation ("Vicarious"), pursuant to which Merger Sub merged with and into Vicarious, with Vicarious surviving as a wholly-owned subsidiary of D8 (which changed its name to "Vicarious Surgical Inc.", the "Issuer"), these stock options were received in exchange for a stock option to acquire 386,015 shares of Vicarious common stock for $1.34 per share.

F1 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments beginning on October 18, 2020, subject to Mr. Styka's continued service through the applicable vesting date.

Read SEC document
September 17, 2021 Filed Sep 24, 2021 01:29 UTC
Berman DrorDirector
GrantClass A Common Stock 13,436,810 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-049655 · ownership.xml · nonDerivative · entry 1

Innovation Endeavors III LP · CIK 0001720215 · 10% owner

Berman Dror · CIK 0001883780 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,436,810

F1 · price: In connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 15, 2021, by and among D8 Holdings Corp. ("D8"), Snowball Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of D8 ("Merger Sub"), and Vicarious Surgical Inc., a Delaware corporation ("Vicarious"), pursuant to which Merger Sub merged with and into Vicarious, with Vicarious surviving as a wholly-owned subsidiary of D8 (which changed its name to "Vicarious Surgical Inc.", the "Issuer"), these shares were received in exchange for 3,313,025 Series A1 Preferred Stock, 456,520 Series A2 Preferred Stock and 304,302 Series A3 Preferred Stock of Vicarious.

F2 · ownership.direct: Dror Berman is a managing partner at Innovation Endeavors III LP and may be deemed to share voting and dispositive power over the shares held by Innovation Endeavors III LP. Such persons and entities disclaim beneficial ownership of shares held by Innovation Endeavors III LP, except to the extent of any pecuniary interest therein.

Read SEC document
September 17, 2021 Filed Sep 27, 2021 17:46 UTC
Morris JuneCLO, General Counsel and Sec
GrantStock Option (right to buy) · Derivative 560,712 Not disclosed Strike: $1.90 Not disclosed
Disclosure

SEC source: 0001213900-21-050083 · ownership.xml · derivative · entry 1

Morris June · CIK 0001884658 · CLO, General Counsel and Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 560,712

Underlying: Class A Common Stock · 560,712 shares

Expires 2031-02-24

F2 · price: In connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 15, 2021, by and among D8 Holdings Corp. ("D8"), Snowball Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of D8 ("Merger Sub"), and Vicarious Surgical Inc., a Delaware corporation ("Vicarious"), pursuant to which Merger Sub merged with and into Vicarious, with Vicarious surviving as a wholly-owned subsidiary of D8 (which changed its name to "Vicarious Surgical Inc.", the "Issuer"), these stock options were received in exchange for a stock option to acquire 170,000 shares of Vicarious common stock for $6.26 per share.

F1 · derivative.exercise_date: The shares underlying this option will vest as to 25% on February 24, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to Ms. Morris' continued service through the applicable vesting date.

Read SEC document
September 17, 2021 Filed Sep 30, 2021 17:23 UTC GrantClass A Common Stock 17,207 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-050853 · ownership.xml · nonDerivative · entry 2

Greene Barry Stuart · CIK 0001885550 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,207

F2 · price: In connection with the Merger, these shares were received in exchange for 5,217 Series A Preferred Stock of Vicarious.

Read SEC document
September 17, 2021 Filed Sep 30, 2021 17:23 UTC GrantClass B Common Stock 3,908,497 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-050853 · ownership.xml · nonDerivative · entry 1

Greene Barry Stuart · CIK 0001885550 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,908,497

F1 · price: In connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 15, 2021, by and among D8 Holdings Corp. ("D8"), Snowball Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of D8 ("Merger Sub"), and Vicarious Surgical Inc., a Delaware corporation ("Vicarious"), pursuant to which Merger Sub merged with and into Vicarious (the "Merger"), with Vicarious surviving as a wholly-owned subsidiary of D8 (which changed its name to "Vicarious Surgical Inc.", the "Issuer"), these shares were received in exchange for 1,185,000 Class A Common Stock of Vicarious.

Read SEC document
September 17, 2021 Filed Sep 30, 2021 17:21 UTC
Sachs Adam DavidDirector · President and CEO · 10% owner
GrantClass B Common Stock 11,329,695 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-050851 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,329,695

F1 · price: In connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 15, 2021, by and among D8 Holdings Corp. ("D8"), Snowball Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of D8 ("Merger Sub"), and Vicarious Surgical Inc., a Delaware corporation ("Vicarious"), pursuant to which Merger Sub merged with and into Vicarious, with Vicarious surviving as a wholly-owned subsidiary of D8 (which changed its name to "Vicarious Surgical Inc.", the "Issuer"), these shares were received in exchange for 3,435,000 Class A Common Stock of Vicarious.

Read SEC document
September 17, 2021 Filed Oct 1, 2021 18:51 UTC
E15 Fund II, LPSole Shareholder
Liang PhilipManaging Partner
GrantClass A Common Stock 10,036,850 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-051193 · ownership.xml · nonDerivative · entry 1

Chelvey International Ltd · CIK 0001884829 · 10% owner

E15 Fund II, LP · CIK 0001885992 · Sole Shareholder

Liang Philip · CIK 0001883781 · Managing Partner

Patnaik Shrikant · CIK 0001885980 · Principal

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,036,850

F1 · price: In connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 15, 2021, by and among D8 Holdings Corp. ("D8"), Snowball Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of D8 ("Merger Sub"), and Vicarious Surgical Inc., a Delaware corporation ("Vicarious"), pursuant to which Merger Sub merged with and into Vicarious, with Vicarious surviving as a wholly-owned subsidiary of D8 (which changed its name to "Vicarious Surgical Inc.", the "Issuer"), these shares were received in exchange for 3,043,028 Series A3 Preferred Stock of Vicarious.

F2 · ownership.direct: E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. Philip Liang is the managing partner of E15 Fund II, LP and Shrikant Patnaik is a principal of E15 Fund II, LP and may be deemed to share voting and dispositive power over the shares held by Chelvey International Limited. Such persons and entities disclaim beneficial ownership of shares held by Chelvey International Limited, except to the extent of any pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.